Medtronic Media Contacts:
Martha Goldberg Aronson, Investor Relations, 763-505-2694
Rob Clark, Public Relations, 763-505-2635
MINNEAPOLIS ?October 15, 2007 ? Medtronic, Inc. (NYSE:MDT) said today that it has voluntarily suspended worldwide distribution of the Sprint Fidelis